13e), albeit to a less striking extent than did GPX4 inhibition, which was likely biased by the higher cell densities required for the knockdown experiments
The AP also has efferent and afferent connections to the hypothalamus, allowing it to moderate feeding in response to the nutritional demands (58, 100)
A small trial including 8 patients with T1D showed improved postprandial hyperglycemia despite 20% insulin dose reduction ( 5 Cardiovascular and renal outcomes with GLP-1RA in T1D In patients with T2D, large RCT studies have shown that GLP-1RA treatment reduces the risk of cardiovascular and renal outcomes ( 6 Practical issues when prescribing GLP-1RA in T1D GLP-1RA are not currently approved for treatment of T1D, but they may still be covered by insurance if prescribed to treat obesity in these patients (although insurance coverage for obesity remains limited)
She is the author of Pregnancy with Type 1 Diabetes, Dealing with Diabetes
For example, tirzepatide may reduce the effectiveness of oral contraceptives, and patients taking warfarin with any GLP-1 receptor agonist should consider more frequent INR monitoring when starting or stopping therapy
Trade-off : Higher discontinuation rates (18.2% high dose vs